Cerus Corporation
CERS
#7519
Rank
A$0.74 B
Marketcap
A$3.72
Share price
-0.38%
Change (1 day)
62.29%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2026 (TTM): -A$1.7 Million

According to Cerus Corporation's latest financial reports the company's current earnings are A$0.21 Billion. In 2025 the company made an earning of -A$9.74 Million, an increase over its 2024 earnings that were of -A$16.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$1.7 Million-82.59%
2025 -A$9.74 Million-41.58%
2024 -A$16.68 Million-58.95%
2023 -A$40.61 Million-20.74%
2022 -A$51.24 Million-25.7%
2021 -A$68.96 Million-11.99%
2020 -A$78.35 Million-14%
2019 -A$91.11 Million21.73%
2018 -A$74.84 Million-0.65%
2017 -A$75.33 Million-10.96%
2016 -A$84.61 Million4.24%
2015 -A$81.17 Million50.99%
2014 -A$53.76 Million-10.08%
2013 -A$59.79 Million184.13%
2012 -A$21.05 Million-7.91%
2011 -A$22.85 Million
2009 -A$32.27 Million-24.69%
2008 -A$42.85 Million-25.2%
2007 -A$57.28 Million330.54%
2006 -A$13.31 Million1.49%
2005 -A$13.11 Million-61.02%
2004 -A$33.64 Million
2002 -A$83.19 Million10.02%
2001 -A$75.62 Million34.25%
2000 -A$56.33 Million61.02%
1999 -A$34.98 Million-18.81%
1998 -A$43.09 Million93.08%
1997 -A$22.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.25 B-343,088.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$18.85 M-1,331.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.21 B-14,466.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$20.94 Million 1,267.28%๐Ÿ‡บ๐Ÿ‡ธ USA